The challenge of methicillin-resistant Staphylococcus aureus prevention in hemodialysis therapy

Seminars in Dialysis

Volumn 25, Issue 1, 2012, Pages 42-49

  Parker, Mark G ^a   Doebbeling, Bradley N ^b,c,d  

^a MAINE MEDICAL CENTER   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c INDIANA UNIVERSITY   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC KIDNEY FAILURE; CROSS INFECTION; DISEASE TRANSMISSION; HEALTH; HEMODIALYSIS; HUMAN; INCIDENCE; INDWELLING CATHETER; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; RENAL REPLACEMENT THERAPY; RISK FACTOR; STAPHYLOCOCCUS INFECTION;

CATHETERS, INDWELLING; CROSS INFECTION; HEMODIALYSIS UNITS, HOSPITAL; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RENAL DIALYSIS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; WORLD HEALTH;

EID: 84856237029     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2011.00999.x     Document Type: Article

References (66)

1. Centers for Disease Control: Invasive methicillin-resistant Staphylococcus aureus infections among dialysis patients-United States, 2005. MMWR 56(9):197-199, 2007.
2. Filice GA, Nyman JA, Lexau C, Lees CH, Bockstedt LA, Como-Sabetti K, Lesher LJ, Lynfield R: Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection. Infect Control Hosp Epidemiol 31(4):365-373, 2010.
3. Gould IM: Community-acquired MRSA: can we control it? Lancet 368(9538):824-826, 2006.
4. Centers for Disease Control: Vital Signs: central line-associated blood stream infections-United States, 2001, 2008, and 2009. MMWR 6:1-6, 2011.
5. Collins AJ, Foley RN, Gilbertson DT, Chen SC: The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol 4(Suppl 1):S5-S11, 2009.
6. Bartlett JG: Methicillin-resistant Staphylococcus aureus infections. Top HIV Med 16(5):151-155, 2008.
7. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA: Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355(7):666-674, 2006.
8. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB: Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39(3):309-317, 2004.
9. National Nosocomial Infections Surveillance (NNIS). System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32(8):470-485, 2004.
10. Asensio A, Guerrero A, Quereda C, Lizan M, Martinez-Ferrer M: Colonization and infection with methicillin-resistant Staphylococcus aureus: associated factors and eradication. Infect Control Hosp Epidemiol 17(1):20-28, 1996.
11. O'Connell B, Marcus R, Broadbent V, Williams MV, Ludlam H: Can a single antibiotic policy for the empirical treatment of febrile neutropenic patients be used for all categories of haematology/oncology patient in the same institution? J Antimicrob Chemother 42(5):677-678, 1998.
12. MacDougall C, Powell JP, Johnson CK, Edmond MB, Polk RE: Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals. Clin Infect Dis 41(4):435-440, 2005.
13. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA: Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 162(19):2229-2235, 2002.
14. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y: The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 26(2):166-174, 2005.
15. Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G, McDougal LK, Fosheim GE, Jensen BJ, Killgore G, Tenover FC, Kuehnert MJ: Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 197(9):1226-1234, 2008.
16. Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR: Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 39(6):776-782, 2004.
17. Suffoletto BP, Cannon EH, Ilkhanipour K, Yealy DM: Prevalence of Staphylococcus aureus nasal colonization in emergency department personnel. Ann Emerg Med 52(5):529-533, 2008.
18. Bisaga A, Paquette K, Sabatini L, Lovell EO: A prevalence study of methicillin-resistant Staphylococcus aureus colonization in emergency department health care workers. Ann Emerg Med 52(5):525-528, 2008.
19. Reboli AC, John JF Jr, Platt CG, Cantey JR: Methicillin-resistant Staphylococcus aureus outbreak at a Veterans' Affairs Medical Center: importance of carriage of the organism by hospital personnel. Infect Control Hosp Epidemiol 11(6):291-296, 1990.
20. Robicsek A, Beaumont JL, Peterson LR: Duration of colonization with methicillin-resistant Staphylococcus aureus. Clin Infect Dis 48(7):910-913, 2009.
21. Boyce JM, Potter-Bynoe G, Chenevert C, King T: Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol 18(9):622-627, 1997.
22. Boyce JM, Havill NL, Otter JA, Adams NM: Widespread environmental contamination associated with patients with diarrhea and methicillin-resistant Staphylococcus aureus colonization of the gastrointestinal tract. Infect Control Hosp Epidemiol 28(10):1142-1147, 2007.
23. Pallotta KE, Manley HJ: Vancomycin use in patients requiring hemodialysis: a literature review. Semin Dial 21(1):63-70, 2008.
24. Tenover FC, Moellering RC Jr: The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin Infect Dis 44(9):1208-1215, 2007.
25. Bogut A, Koziol-Montewka M, Baranowicz I, Jozwiak L, Ksiazek A, Al-Doori Z, Morrison D, Kaczor D, Paluch-Oles J: Characterisation of Staphylococcus aureus nasal and skin carriage among patients undergoing haemodialysis treatment. New Microbiol 30(2):149-154, 2007.
26. Lederer SR, Riedelsdorf G, Schiffl H: Nasal carriage of methicillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients. Eur J Med Res 12(7):284-288, 2007.
27. Hadley AC, Karchmer TB, Russell GB, McBride DG, Freedman BI: The prevalence of resistant bacterial colonization in chronic hemodialysis patients. Am J Nephrol 27(4):352-359, 2007.
28. Lu PL, Tsai JC, Chiu YW, Chang FY, Chen YW, Hsiao CF, Siu LK: Methicillin-resistant Staphylococcus aureus carriage, infection and transmission in dialysis patients, healthcare workers and their family members. Nephrol Dial Transplant 23(5):1659-1665, 2008.
29. Pop-Vicas A, Strom J, Stanley K, D'Agata EM: Multidrug-resistant gram-negative bacteria among patients who require chronic hemodialysis. Clin J Am Soc Nephrol 3(3):752-758, 2008.
30. Lai CF, Liao CH, Pai MF, Chu FY, Hsu SP, Chen HY, Yang JY, Chiu YL, Peng YS, Chang SC, Hung KY, Tsai TJ, Wu KD: Nasal carriage of methicillin-resistant Staphylococcus aureus is associated with higher all-cause mortality in hemodialysis patients. Clin J Am Soc Nephrol 6(1):167-174, 2011.
31. Johnson LB, Jose J, Yousif F, Pawlak J, Saravolatz LD: Prevalence of colonization with community-associated methicillin-resistant Staphylococcus aureus among end-stage renal disease patients and healthcare workers. Infect Control Hosp Epidemiol 30(1):4-8, 2009.
32. Fluck R, Wilson J, Tomson CR: UK Renal Registry 12th Annual Report (December 2009): chapter 12: epidemiology of methicillin resistant Staphylococcus aureus bacteraemia amongst patients receiving dialysis for established renal failure in England in 2008: a joint report from the UK Renal Registry and the Health Protection Agency. Nephron Clin Pract 115(Suppl 1):c261-c270, 2010.
33. Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, Ray SM, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Patel PR, Fridkin SK: Health care-associated invasive MRSA infections, 2005-2008. JAMA 304(6):641-648, 2010.
34. US Department of Health and Human Services and Centers for Medicare and Medicaid Services: Medicare and Medicaid Programs: Conditions for Coverage for End-Stage Renal Disease Facilities; final rule (42 CFR, parts 405, 410, 413, 414, 488, and 494). Fed Reg 203702008.
35. Minary-Dohen P, Bailly P, Bertrand X, Talon D: Methicillin-resistant Staphylococcus aureus (MRSA) in rehabilitation and chronic-care-facilities: what is the best strategy? BMC Geriatr 3:5-10, 2003.
36. Klevens RM, Edwards JR, Andrus ML, Peterson KD, Dudeck MA, Horan TC: Dialysis Surveillance Report: National Healthcare Safety Network (NHSN)-data summary for 2006. Semin Dial 21(1):24-28, 2008.
37. Lynch JR, Wasse H, Armistead NC, McClellan WM: Achieving the goal of the Fistula First breakthrough initiative for prevalent maintenance hemodialysis patients. Am J Kidney Dis 57(1):78-89, 2011.
38. Allon M: Fistula first: recent progress and ongoing challenges. Am J Kidney Dis 57(1):3-6, 2011.
39. Himmelfarb J, Berns A, Szczech L, Wesson D: Cost, quality, and value: the changing political economy of dialysis care. J Am Soc Nephrol 18(7):2021-2027, 2007.
40. Patel PR, Kallen AJ, Arduino MJ: Epidemiology, surveillance, and prevention of bloodstream infections in hemodialysis patients. Am J Kidney Dis 56(3):566-577, 2010.
41. Kallen AJ, Arduino MJ, Patel PR: Preventing infections in patients undergoing hemodialysis. Expert Rev Anti Infect Ther 8(6):643-655, 2010.
42. James MT, Conley J, Tonelli M, Manns BJ, MacRae J, Hemmelgarn BR: Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med 148(8):596-605, 2008.
43. Sesso R, Barbosa D, Leme IL, Sader H, Canziani ME, Manfredi S, Draibe S, Pignatari AC: Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. J Am Soc Nephrol 9(6):1085-1092, 1998.
44. Johnson DW, MacGinley R, Kay TD, Hawley CM, Campbell SB, Isbel NM, Hollett P: A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant 17(10):1802-1807, 2002.
45. Patel JB, Gorwitz RJ, Jernigan JA: Mupirocin resistance. Clin Infect Dis 49(6):935-941, 2009.
46. Barraclough KA, Hawley CM, Playford EG, Johnson DW: Prevention of access-related infection in dialysis. Expert Rev Anti Infect Ther 7(10):1185-1200, 2009.
47. Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, Luxton G, Moody H: Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 13(8):2133-2139, 2002.
48. Saxena AK, Panhotra BR, Sundaram DS, Al-Hafiz A, Naguib M, Venkateshappa CK, bu-Oun BA, Hussain SM, Al-Ghamdi AA: Tunneled catheters' outcome optimization among diabetics on dialysis through antibiotic-lock placement. Kidney Int 70(9):1629-1635, 2006.
49. Safdar N, Maki DG: Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin Infect Dis 43(4):474-484, 2006.
50. Winnett G, Nolan J, Miller M, Ashman N: Trisodium citrate 46.7% selectively and safely reduces staphylococcal catheter-related bacteraemia. Nephrol Dial Transplant 23(11):3592-3598, 2008.
51. Takla TA, Zelenitsky SA, Vercaigne LM: Effect of ethanol/trisodium citrate lock on microorganisms causing hemodialysis catheter-related infections. J Vasc Access 8(4):262-267, 2007.
52. Sedlacek M, Gemery JM, Cheung AL, Bayer AS, Remillard BD: Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters. Am J Kidney Dis 49(3):401-408, 2007.
53. Ellingson K, Muder RR, Jain R, Kleinbaum D, Feng PJ, Cunningham C, Squier C, Lloyd J, Edwards J, Gebski V, Jernigan J: Sustained reduction in the clinical incidence of methicillin-resistant Staphylococcus aureus colonization or infection associated with a multifaceted infection control intervention. Infect Control Hosp Epidemiol 32(1):1-8, 2011.
54. Nyman JA, Lees CH, Bockstedt LA, Filice GA, Lexau C, Lesher LJ, Como-Sabetti K, Lynfield R: Cost of screening intensive care unit patients for methicillin-resistant Staphylococcus aureus in hospitals. Am J Infect Control 39(1):27-34, 2011.
55. Hacek DM, Paule SM, Thomson RB Jr, Robicsek A, Peterson LR: Implementation of a universal admission surveillance and decolonization program for methicillin-resistant Staphylococcus aureus (MRSA) reduces the number of MRSA and total number of S. aureus isolates reported by the clinical laboratory. J Clin Microbiol 47(11):3749-3752, 2009.
56. Fraser TG, Fatica C, Scarpelli M, Arroliga AC, Guzman J, Shrestha NK, Hixson E, Rosenblatt M, Gordon SM, Procop GW: Decrease in Staphylococcus aureus colonization and hospital-acquired infection in a medical intensive care unit after institution of an active surveillance and decolonization program. Infect Control Hosp Epidemiol 31(8):779-783, 2010.
57. Bowler WA, Bresnahan J, Bradfish A, Fernandez C: An integrated approach to methicillin-resistant Staphylococcus aureus control in a rural, regional-referral healthcare setting. Infect Control Hosp Epidemiol 31(3):269-275, 2010.
58. Yu VL, Goetz A, Wagener M, Smith PB, Rihs JD, Hanchett J, Zuravleff JJ: Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med 315(2):91-96, 1986.
59. Sandri AM, Dalarosa MG, Ruschel de AL, da Silva EL, Zavascki AP: Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp Epidemiol 27(2):185-187, 2006.
60. Buehlmann M, Frei R, Fenner L, Dangel M, Fluckiger U, Widmer AF: Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers. Infect Control Hosp Epidemiol 29(6):510-516, 2008.
61. Centers for Disease Control. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 50(RR-5):1-43, 2001.
62. Osono E, Takahashi M, Kurihara S, Ohwada K, Sakurai Y, Onoda N, Takeuchi M, Yoneshima H, Hayama N, Iino Y, Saji M, Shikita R, Takahashi H, Ohkuni H: Effects of "isolating hemodialysis" on prevention of methicillin-resistant Staphylococcus aureus cross-infection in a hemodialysis unit. Clin Nephrol 54(2):128-133, 2000.
63. Rangachari P: Knowledge sharing and organizational learning in the context of hospital infection prevention. Qual Manag Health Care 19(1):34-46, 2010.
64. Marsh DR, Schroeder DG, Dearden KA, Sternin J, Sternin M: The power of positive deviance. BMJ 329(7475):1177-1179, 2004.
65. Bradley EH, Curry LA, Ramanadhan S, Rowe L, Nembhard IM, Krumholz HM: Research in action: using positive deviance to improve quality of health care. Implement Sci 4:25-34, 2009.
66. Curtin J, Dalziel C: Beat Those Bugs! Implementing contact precautions in community dialysis units for closer-to-home care. Can J Infect Control 25(1):9-16, 2010.